HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 13 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,439 | -6.5% | 49,998 | 0.0% | 0.01% | +11.1% |
| Q2 2023 | $35,771 | +19.5% | 49,998 | 0.0% | 0.01% | -40.0% |
| Q1 2023 | $29,936 | -48.4% | 49,998 | 0.0% | 0.02% | -16.7% |
| Q3 2022 | $58,000 | +28.9% | 49,998 | 0.0% | 0.02% | +5.9% |
| Q2 2022 | $45,000 | -53.6% | 49,998 | 0.0% | 0.02% | -46.9% |
| Q1 2022 | $97,000 | -14.9% | 49,998 | 0.0% | 0.03% | -5.9% |
| Q4 2021 | $114,000 | -21.4% | 49,998 | 0.0% | 0.03% | -26.1% |
| Q3 2021 | $145,000 | – | 49,998 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 194,718 | $171,000 | 0.22% |
| RPO LLC | 83,705 | $74,000 | 0.02% |
| Sio Capital Management, LLC | 49,998 | $45,000 | 0.02% |
| CVI Holdings, LLC | 244,825 | $218,000 | 0.02% |
| Exos Asset Management LLC | 27,151 | $24,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 236,549 | $208,000 | 0.01% |
| LMR Partners LLP | 50,000 | $161,000 | 0.00% |
| P SCHOENFELD ASSET MANAGEMENT LP | 19,155 | $17,000 | 0.00% |
| Verition Fund Management LLC | 15,000 | $48,000 | 0.00% |
| JANE STREET GROUP, LLC | 56,444 | $50,000 | 0.00% |